CNS Brainstorm Episode 47 "Neurofibromatosis Type 1 or NF1" with guest Kathryn Xixis, MD and guest host Jeffrey Strelzik, MD
Child Neurology Society's Brainstorm
00:00
Treatment: symptomatic care and MEK inhibitors
Catherine Sixes reviews symptomatic management and FDA approvals of selumetinib and mertimetinib for symptomatic, inoperable plexiform neurofibromas.
Play episode from 22:35
Transcript
